Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy
- PMID: 25945346
- PMCID: PMC4405013
- DOI: 10.1155/2015/794378
Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy
Abstract
The oxygen-derived free radicals that are released from activated neutrophils are one of the cytotoxic factors of Helicobacter pylori-induced gastric mucosal injury. Increased cytidine deaminase activity in H. pylori-infected gastric tissues promotes the accumulation of various mutations and might promote gastric carcinogenesis. Cytotoxin-associated gene A (CagA) is delivered into gastric epithelial cells via bacterial type IV secretion system, and it causes inflammation and activation of oncogenic pathways. H. pylori infection induces epigenetic transformations, such as aberrant promoter methylation in tumor-suppressor genes. Aberrant expression of microRNAs is also reportedly linked to gastric tumorogenesis. Moreover, recent advances in molecular targeting therapies provided a new interesting weapon to treat advanced gastric cancer through anti-human epidermal growth factor receptor 2 (HER-2) therapies. This updated review article highlights possible mechanisms of gastric carcinogenesis including H. pylori-associated factors.
Figures
Similar articles
-
CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis.Gut. 2013 Nov;62(11):1536-46. doi: 10.1136/gutjnl-2011-301625. Epub 2012 Aug 30. Gut. 2013. PMID: 22936674
-
MicroRNA-320a and microRNA-4496 attenuate Helicobacter pylori cytotoxin-associated gene A (CagA)-induced cancer-initiating potential and chemoresistance by targeting β-catenin and ATP-binding cassette, subfamily G, member 2.J Pathol. 2017 Apr;241(5):614-625. doi: 10.1002/path.4866. Epub 2017 Feb 17. J Pathol. 2017. PMID: 28008607
-
Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway.Mol Carcinog. 2019 Aug;58(8):1427-1437. doi: 10.1002/mc.23025. Epub 2019 Jun 4. Mol Carcinog. 2019. PMID: 31162747
-
Role of Helicobacter pylori virulence factor cytotoxin-associated gene A in gastric mucosa-associated lymphoid tissue lymphoma.World J Gastroenterol. 2013 Dec 7;19(45):8219-26. doi: 10.3748/wjg.v19.i45.8219. World J Gastroenterol. 2013. PMID: 24363512 Free PMC article. Review.
-
Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis.World J Gastroenterol. 2015 Dec 7;21(45):12742-56. doi: 10.3748/wjg.v21.i45.12742. World J Gastroenterol. 2015. PMID: 26668499 Free PMC article. Review.
Cited by
-
Advancements in Free-Radical Pathologies and an Important Treatment Solution with a Free-Radical Inhibitor.SF J Biotechnol Biomed Eng. 2018;1(1):1003. Epub 2018 Feb 21. SF J Biotechnol Biomed Eng. 2018. PMID: 29984367 Free PMC article.
-
Effects of patient age and choice of antisecretory agent on success of eradication therapy for Helicobacter pylori infection.J Clin Biochem Nutr. 2017 May;60(3):208-210. doi: 10.3164/jcbn.16-86. Epub 2017 Feb 16. J Clin Biochem Nutr. 2017. PMID: 28584402 Free PMC article.
-
Endoscopic Kyoto classification of Helicobacter pylori infection and gastric cancer risk diagnosis.World J Gastroenterol. 2020 Feb 7;26(5):466-477. doi: 10.3748/wjg.v26.i5.466. World J Gastroenterol. 2020. PMID: 32089624 Free PMC article. Review.
-
HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters.Dis Markers. 2019 Oct 14;2019:6315936. doi: 10.1155/2019/6315936. eCollection 2019. Dis Markers. 2019. PMID: 31737131 Free PMC article.
-
Characteristics of gastric cancer detected within 1 year after successful eradication of Helicobacter pylori.J Clin Biochem Nutr. 2016 Nov;59(3):226-230. doi: 10.3164/jcbn.16-43. Epub 2016 Aug 24. J Clin Biochem Nutr. 2016. PMID: 27895391 Free PMC article.
References
-
- Fukase K., Kato M., Kikuchi S., et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. The Lancet. 2008;372(9636):392–397. doi: 10.1016/S0140-6736(08)61159-9. - DOI - PubMed
-
- Fuccio L., Zagari R. M., Eusebi L. H., Laterza L., Cennamo V., Ceroni L. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Annals of Internal Medicine. 2009;151(7):121–128. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous